e-learning
resources
Virtual 2021
05.09.2021
Pathophysiology and clinical consequences of obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The platelet-lymphocyte ratio as a marker of the severity of the obstructive sleep apnea-hypopnea syndrome: fact or fiction?
S. Kallel (sfax, Tunisia), E. Jameleddine (Sfax, Tunisia), K. Kchaou (Sfax, Tunisia), M. Chaabouni (Sfax, Tunisia), M. Mnejja (Sfax, Tunisia), I. Charfeddine (Sfax, Tunisia)
Source:
Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Session:
Pathophysiology and clinical consequences of obstructive sleep apnoea
Session type:
E-poster
Number:
364
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Kallel (sfax, Tunisia), E. Jameleddine (Sfax, Tunisia), K. Kchaou (Sfax, Tunisia), M. Chaabouni (Sfax, Tunisia), M. Mnejja (Sfax, Tunisia), I. Charfeddine (Sfax, Tunisia). The platelet-lymphocyte ratio as a marker of the severity of the obstructive sleep apnea-hypopnea syndrome: fact or fiction?. 364
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
C-reactive protein levels can predict obstructive sleep apnea / hypopnea syndrome?
Source: Eur Respir J 2004; 24: Suppl. 48, 118s
Year: 2004
Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity?
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
Polygraphy: can we really rely on it in the diagnosis of obstructive sleep apnoea/hypopnoea syndrome?
Source: Annual Congress 2009 - What is the best screening method for obstructive sleep apnoea/hypopnoea syndrome?
Year: 2009
Polysomnography: do we still need it in the diagnosis of obstructive sleep apnoea/hypopnoea syndrome?
Source: Annual Congress 2009 - What is the best screening method for obstructive sleep apnoea/hypopnoea syndrome?
Year: 2009
Can snoring intensity predict high blood pressure in the obstructive sleep apnea-hypopnea syndrome?
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021
A new index in the definition of the severity of obstructive sleep apnea syndrome (OSAS): apnoea-hypopnoea duration index (AHDI)
Source: Eur Respir J 2003; 22: Suppl. 45, 273s
Year: 2003
Association of obstructive sleep apnea hypopnea syndrome with cardiovascular disease: a candidate gene association study
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
High Mallampati score and nasal obstruction are associated risk factors for obstructive sleep apnoea
Source: Eur Respir J 2003; 21: 248-252
Year: 2003
Relationship between obstructive sleep apnea syndrome severity and age
Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea
Year: 2011
Clinical characteristics of patients derived for suspicion of obstructive sleep apnea-hipopnea syndrome to a sleep disorders unit: Does age matter?
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome?
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
The controversial link between obesity and obstructive sleep apnea-hypopnea syndrome in pediatric population
Source: Annual Congress 2010 - Adenotonsillectomy and paediatric sleep medicine
Year: 2010
Does low plasma adiponectin level affect cardiovasculer risk in obstructive sleep apnea syndrome?
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
More than the apnoea-hypopnea index: an integrated approach to obstructive sleep apnoea
Source: 5th Sleep and Breathing Conference
Year: 2019
BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 40s
Year: 2005
S100B protein: A useful marker in obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Body surface area as a tool for predicting the severity of obstructive apnea hypopnea syndrome
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021
The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
Driving towards a change to DVLA reporting in obstructive sleep apnoea/hypopnoea syndrome?
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept